Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 11,761–11,780 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

CROCODILE BILE PILL FOR ASTHMA, packaged in 100-count bottles within a box, remaining labeling contains Chinese characters.

by Murray International Trading Co., Inc.

Reason
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

SCIATICA PILLS, packaged in 120-count bottles within a box, Made in the Peoples Republic of China, remaining labeling contains Chinese characters.

by Murray International Trading Co., Inc.

Reason
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.

by Murray International Trading Co., Inc.

Reason
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

ChingChunBao ANTI-AGING TABLETS, packaged in 80-count bottles within a box, UPC 0 49987 01144 9, remaining labeling contains Chinese characters.

by Murray International Trading Co., Inc.

Reason
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

PATCH-REMOUING PILL (For Facial Pigmentation), packaged in a bottle within a box, Kwang Chow Pharm. Ind. Corp., remaining labeling contains Chinese characters.

by Murray International Trading Co., Inc.

Reason
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Sufentanil Citrate 0.4mcg/mL & Bupivacaine 0.1% in 0.9% Sodium Chloride 250 mL Intravia Bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN, NDC 45183-0996-02

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Bupivacaine HCI 0.25% in 0.9% Sodium Chloride, 500 mL Intravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0994-03

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Midazolam HCl 1mg/mL in 0.9% Sodium Chloride, 50 mL Intravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0989-41

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Vecuronium 1mg/mL in Sterile Water ,10 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0972-72

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Rocuronium 10mg/ml 10ml fill in a 10ml BD syringe; Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0971-72

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Midazolam HCI 1mg/mL in 0.9% Sodium Chloride ,2 mL fill in a 3 mL syringe; Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0966-69

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl Citrate 50 mcg/mL, 5ml syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0964-70

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Ephedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, 10 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0961-72

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Cefazolin 1GM in Sterile Water, 10 ml BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0960-72

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Ondansetron 2mg/mL, 2 mL fill in a 3 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0957-69

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Rocuronium 10 mg/mL, 5 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0955-70

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine 2%, 5 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0946-70

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Ropivacaine HCI 0.2% in 0.9% Sodium Chloride, 500mL lntravia bag, Rx only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0942-03

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Ephedrine Sulfate 5 mg/ml in 0.9% Sodium Chloride, 5 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0939-70

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Drug Recall Terminated Historical recordClass II

Ketamine 2 mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0938-68

by Pharmakon Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
April 20, 2016
Reported by FDA
July 20, 2016
Distribution
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.